STOCKINGER, Eva, SAGAR, LUXENBURGER, Hendrik, BETTINGER, Dominik, BERLIN, Christopher, OBWEGS, David, STURM, Lukas, GROMAK, Mikhail, GAIRING, Simon J., FOERSTER, Friedrich, LABENZ, Christian, MACNELLY, Sabine, BÖTTLER, Tobias, HOLZNER, Philipp Anton, BRONSERT, Peter, BENGSCH, Bertram, THIMME, Robert, HOFMANN, Maike und RÖHLEN, Natascha, 2024. MCAM is a prognostic biomarker in patients with liver cirrhosis and HCC. Freiburg: Universität.
Elsevier - Harvard (with titles)Stockinger, E., Sagar, Luxenburger, H., Bettinger, D., Berlin, C., Obwegs, D., Sturm, L., Gromak, M., Gairing, S.J., Foerster, F., Labenz, C., Mac Nelly, S., Böttler, T., Holzner, P.A., Bronsert, P., Bengsch, B., Thimme, R., Hofmann, M., Röhlen, N., 2024. MCAM is a prognostic biomarker in patients with liver cirrhosis and HCC. Universität, Freiburg. https://doi.org/10.1097/hc9.0000000000000532
American Psychological Association 7th editionStockinger, E., Sagar, Luxenburger, H., Bettinger, D., Berlin, C., Obwegs, D., Sturm, L., Gromak, M., Gairing, S. J., Foerster, F., Labenz, C., Mac Nelly, S., Böttler, T., Holzner, P. A., Bronsert, P., Bengsch, B., Thimme, R., Hofmann, M., & Röhlen, N. (ca. 2024). MCAM is a prognostic biomarker in patients with liver cirrhosis and HCC [Cd]. Universität. https://doi.org/10.1097/hc9.0000000000000532
Springer - Basic (author-date)Stockinger E, Sagar, Luxenburger H, Bettinger D, Berlin C, Obwegs D, Sturm L, Gromak M, Gairing SJ, Foerster F, Labenz C, Mac Nelly S, Böttler T, Holzner PA, Bronsert P, Bengsch B, Thimme R, Hofmann M, Röhlen N (2024) MCAM is a prognostic biomarker in patients with liver cirrhosis and HCC. Universität, Freiburg
Juristische Zitierweise (Stüber) (Deutsch)Stockinger, Eva/ Sagar/ Luxenburger, Hendrik/ Bettinger, Dominik/ Berlin, Christopher/ Obwegs, David/ Sturm, Lukas/ Gromak, Mikhail/ Gairing, Simon J./ Foerster, Friedrich/ Labenz, Christian/ Mac Nelly, Sabine/ Böttler, Tobias/ Holzner, Philipp Anton/ Bronsert, Peter/ Bengsch, Bertram/ Thimme, Robert/ Hofmann, Maike/ Röhlen, Natascha, MCAM is a prognostic biomarker in patients with liver cirrhosis and HCC, Freiburg 2024.